Your browser doesn't support javascript.
loading
Brentuximab vedotin consolidation therapy after autologous stem-cell transplantation in patients with high-risk Hodgkin lymphoma: Multicenter retrospective study.
Akay, Olga Meltem; Ozbalak, Murat; Pehlivan, Mustafa; Yildiz, Birol; Uzay, Ant; Yigenoglu, Tugce Nur; Elverdi, Tugrul; Kaynar, Leylagul; Ayyildiz, Orhan; Yonal Hindilerden, Ipek; Goksoy, Hasan Sami; Izmir Guner, Sebnem; Gunes, Ahmet Kursad; Sonmez, Mehmet; Kurt Yuksel, Meltem; Civriz Bozdag, Sinem; Ozkurt, Zubeyde Nur; Toptas, Tayfur; Dogu, Mehmet Hilmi; Salim, Ozan; Saydam, Guray; Yavasoglu, Irfan; Ayli, Meltem; Ozet, Gulsum; Albayrak, Murat; Birtas Atesoglu, Elif; Toprak, Selami K; Yildirim, Rahsan; Mehtap, Ozgur; Kalayoglu Besisik, Sevgi; Nalcaci, Meliha; Altuntas, Fevzi; Ferhanoglu, Burhan.
Afiliação
  • Akay OM; Department of Internal Medicine, Division of Hematology, Koç University Medical Faculty, Istanbul, Turkey.
  • Ozbalak M; Department of Internal Medicine, Division of Hematology, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey.
  • Pehlivan M; Department of Internal Medicine, Division of Hematology, Gaziantep University Medical Faculty, Gaziantep, Turkey.
  • Yildiz B; Department of Internal Medicine, Division of Medical Oncology, Gulhane Research and Training Hospital, Ankara, Turkey.
  • Uzay A; Depatment of Hematology, Acibadem University Medical Faculty, Istanbul, Turkey.
  • Yigenoglu TN; Division of Hematology, Dr. Abdurrahman Yurtaslan Ankara Oncology Research and Training Hospital, Ankara, Turkey.
  • Elverdi T; Department of Internal Medicine, Division of Hematology, Istanbul University Cerrahpasa Medical Faculty, Istanbul, Turkey.
  • Kaynar L; Department of Internal Medicine, Division of Hematology, Erciyes University Medical Faculty, Kayseri, Turkey.
  • Ayyildiz O; Department of Internal Medicine, Division of Hematology, Dicle University Medical Faculty, Diyarbakir, Turkey.
  • Yonal Hindilerden I; Department of Internal Medicine, Division of Hematology, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey.
  • Goksoy HS; Depatment of Hematology, Yeniyuzyil University Gaziosmanpasa Hospital, Istanbul, Turkey.
  • Izmir Guner S; Depatment of Hematology, Memorial Sisli Hospital, Istanbul, Turkey.
  • Gunes AK; Depatment of Hematology, Mehmet Akif Inan Hospital, Sanliurfa, Turkey.
  • Sonmez M; Department of Internal Medicine, Division of Hematology, Karadeniz Technical University, Trabzon, Turkey.
  • Kurt Yuksel M; Department of Internal Medicine, Division of Hematology, Ankara University Medical Faculty, Ankara, Turkey.
  • Civriz Bozdag S; Department of Internal Medicine, Division of Hematology, Ankara University Medical Faculty, Ankara, Turkey.
  • Ozkurt ZN; Department of Internal Medicine, Division of Hematology, Gazi University Medical Faculty, Ankara, Turkey.
  • Toptas T; Department of Internal Medicine, Division of Hematology, Marmara University Medical Faculty, Istanbul, Turkey.
  • Dogu MH; Division of Hematology, Istanbul Research and Training Hospital, Istanbul, Turkey.
  • Salim O; Department of Internal Medicine, Division of Hematology, Akdeniz University Medical Faculty, Antalya, Turkey.
  • Saydam G; Department of Internal Medicine, Division of Hematology, Ege University Medical Faculty, Izmir, Turkey.
  • Yavasoglu I; Department of Internal Medicine, Division of Hematology, Adnan Menderes University Medical Faculty, Aydin, Turkey.
  • Ayli M; Department of Internal Medicine, Division of Medical Oncology, Gulhane Research and Training Hospital, Ankara, Turkey.
  • Ozet G; Division of Hematology, Ankara City Hospital, Ankara, Turkey.
  • Albayrak M; Division of Hematology, Diskapi Research and Training Hospital, Ankara, Turkey.
  • Birtas Atesoglu E; Division of Hematology, Anadolu Medical Center, Izmit, Turkey.
  • Toprak SK; Department of Internal Medicine, Division of Hematology, Ankara University Medical Faculty, Ankara, Turkey.
  • Yildirim R; Department of Internal Medicine, Division of Hematology, Ataturk University Medical Faculty, Erzurum, Turkey.
  • Mehtap O; Department of Internal Medicine, Division of Hematology, Kocaeli University Medical Faculty, Izmit, Turkey.
  • Kalayoglu Besisik S; Department of Internal Medicine, Division of Hematology, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey.
  • Nalcaci M; Department of Internal Medicine, Division of Hematology, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey.
  • Altuntas F; Division of Hematology, Dr. Abdurrahman Yurtaslan Ankara Oncology Research and Training Hospital, Ankara, Turkey.
  • Ferhanoglu B; Department of Internal Medicine, Division of Hematology, Koç University Medical Faculty, Istanbul, Turkey.
Hematol Oncol ; 39(4): 498-505, 2021 Oct.
Article em En | MEDLINE | ID: mdl-34171130
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Hodgkin / Transplante de Células-Tronco Hematopoéticas / Condicionamento Pré-Transplante / Brentuximab Vedotin Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Humans / Middle aged Idioma: En Revista: Hematol Oncol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Turquia
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Hodgkin / Transplante de Células-Tronco Hematopoéticas / Condicionamento Pré-Transplante / Brentuximab Vedotin Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Humans / Middle aged Idioma: En Revista: Hematol Oncol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Turquia